| Literature DB >> 32782835 |
Arman Tsaturyan1,2, Mher Beglaryan3, Yervand Kirakosyan1, Davit Martirosyan1, Mher Mkhitaryan4, Varujan Shahsuvaryan1, Sergey Fanarjyan1, Ashot Tsaturyan2.
Abstract
INTRODUCTION: The aim of this article was to compare patients' health-related quality of life (HR-QoL) outcomes between ileal orthotopic neobladder (IONB) and standard bilateral cutaneous ureterostomy (CU) using validated diversion-specific HR-QoL questionnaires.Entities:
Keywords: cutaneous ureterostomy; health-related quality of life; orthotopic neobladder; radical cystectomy; urinary diversion
Year: 2020 PMID: 32782835 PMCID: PMC7407788 DOI: 10.5173/ceju.2020.0028
Source DB: PubMed Journal: Cent European J Urol ISSN: 2080-4806
Baseline and operative characteristics of study population
| Patients | Total (n-126) | Surgical technique | |
|---|---|---|---|
| CU (n-57) | IONB (n-69) | ||
| Age (years), median (IQR) | 61 (54–66) | 65 (59–71) | 57 (38–70) |
| Age <65 years, n (%) | 88 (69.8) | 29 (50.9) | 59 (85.5) |
| BMI (kg/m2), median (IQR) | 27.6 (23.6–29.8) | 26.8 (23.2–29.4) | 27.6 (23.6–30.2) |
| Preoperative hydronephrosis, n (%) | 21 (16.7) | 15 (26.3) | 6 (8.7) |
| Diabetes, n (%) | 16 (12.3) | 8 (14.0) | 8 (11.6) |
| Cancer stage, n (%) | |||
| Tumor Grade, n (%) | |||
| Blood loss (ml), median (IQR) | 400 (350–450) | 400 (350–450) | 400(350–450) |
| ASA score (3 and 4), n (%) | 43 (34.1) | 22 (38.6) | 21 (30.4) |
| Follow-up (months), median (IQR) | 45 (30–60) | 36 (26–51) | 50 (38–70) |
| Follow-up >36 months, n (%) | 84 (66.7) | 55 (79.7) | 29 (50.9) |
| Early complications, n (%) | 26 (20.6) | 7 (12.3) | 19 (27.5) |
| Early major complications, n (%) | 13 (10.3) | 1 (1.8) | 12 (17.4) |
| Late complications, n (%) | 53 (42.0) | 23 (40.4) | 30 (43.5) |
BMI – body mass index; CU – cutaneous ureterostomy; IONB – ileal orthotopic neobladder; ASA – American Society of Anesthesiologists; SD – standard deviation; IQR – interquartile range
Bivariate analyses of the type of urinary diversion and patients’ quality of life domains (EORTC-QLQ-C30)
| Patients | Total (n-126) | Surgical technique | P-value | |
|---|---|---|---|---|
| CU (n-57) | IONB (n-69) | |||
| Global health status | 51.0 (18.0) | 42.6 (12.7) | 58.1 (18.9) | <0.001 |
| Physical functioning | 62.6 (19.1) | 57.9 (18.2) | 66.5 (19.0) | 0.012 |
| Emotion functioning | 73.3 (15.8) | 72.4 (14.6) | 74.0 (16.8) | 0.559 |
| Social functioning | 57.1 (19.8) | 53.2 (21.9) | 60.4 (17.4) | 0.043 |
| Role functioning | 69.2 (16.4) | 68.8 (17.1) | 69.6 (15.9) | 0.793 |
| Cognitive functioning | 78.2 (13.7) | 78.1 (13.4) | 78.3 (14.1) | 0.939 |
| Symptoms scale | 42.4 (14.5) | 40.9 (8.9) | 43.7 (17.8) | 0.289 |
EORTC-QLQ-C30 – European Association of Research and Treatment of Cancer Quality of Life Core Questionnaire; SD – standard deviation; IQR – interquartile range
Bivariate analyses of type of the urinary diversion and patients’ quality of life (FACT-Bl-Cys)
| Patients | Total (n-126) | Surgical technique | P-value | |
|---|---|---|---|---|
| CU (n-57) | IONB (n-69) | |||
| Physical health | 18.4 (4.9) | 17.6 (4.4) | 19.1 (5.2) | 0.097 |
| Social health | 19.2 (4.4) | 18.8 (4.6) | 19.6 (4.2) | 0.316 |
| Emotional health | 18.0 (4.2) | 17.7 (3.8) | 18.3 (4.5) | 0.484 |
| Functional health | 13.8 (4.5) | 11.9 (3.2) | 15.3 (4.8) | <0.001 |
| Additional concerns | 36.9 (7.4) | 35.7 (5.0) | 38.0 (8.9) | 0.081 |
| Total score | 106.3 (20.4) | 101.7 (15.4) | 110.1 (23.2) | 0.019 |
FACT-Bl-Cys – Functional Assessment of Cancer Therapy for patients undergoing radical cystectomy questionnaire; SD – standard deviation; IQR – interquartile range
Final multivariable linear regression results
| QoL health domains Factors | Coefficient (Standard error) | Confidence Interval | P-value |
|---|---|---|---|
| EORTC-QLQ-C30 | |||
| Global health status | |||
| Urinary diversion – IONB | 16.2 (3.1) | 10.0–22.4 | <0.001 |
| Cancer stage – Locally advanced (pT3-4a, N0, M0) | NS | ||
| Physical functioning | |||
| Urinary diversion – IONB | 9.1 (3.5) | 2.1–16.0 | 0.011 |
| Late complications – yes | 6.5 (3.3) | 0.1–13.0 | 0.047 |
| Cancer stage – Locally advanced (pT3-4a, N0, M0) | NS | ||
| Symptom scale | |||
| Early major complications – yes | 8.8 (4.2) | 0.4–17.3 | 0.041 |
| Late complications – yes | 5.8 (2.5) | 0.7–0.8 | 0.025 |
| FACT-Bl-Cys | |||
| Physical health | |||
| Early major complications – yes | 3.7 (1.4) | 0.9–6.5 | 0.009 |
| Late complications – yes | 1.8 (0.8) | 0.1–3.4 | 0.036 |
| Cancer stage – locally advanced (pT3-4a, N0, M0) | NS | ||
| Functional health | |||
| Urinary diversion – IONB | 3.8 (0.8) | 2.3–5.3 | <0.001 |
| Cancer stage – locally advanced (pT3-4a, N0, M0) | NS | ||
| Additional concern | |||
| Late complications – yes | 3.1 (1.3) | 0.6–5.7 | 0.016 |
| Total score | |||
| Urinary diversion – IONB | 9.9 (3.7) | 2.5–17.3 | 0.009 |
| Early major complications – no | 14.9 (5.8) | 3.3–26.4 | 0.012 |
| Late complications – no | 8.3 (3.5) | 1.4–15.1 | 0.019 |
| Cancer stage – locally advanced (pT3-4a, N0, M0) | NS | ||
QoL – quality of life; EORTC-QLQ-C30 – European Association of Research and Treatment of Cancer Quality of Life Core Questionnaire; IONB – Ileal orthotopic neobladder; FACT-Bl-Cys - Functional Assessment of Cancer Therapy for patients undergoing radical cystectomy questionnaire
Comparison groups: urinary diversion – cutaneous ureterostomy; cancer stage – bladder confined (pT1-2, N0, M0); Early major complications – Yes; Late complications – Yes